| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1501042
[patent_doc_number] => 06486181
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-26
[patent_title] => 'Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states'
[patent_app_type] => B1
[patent_app_number] => 09/691845
[patent_app_country] => US
[patent_app_date] => 2000-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 39
[patent_no_of_words] => 15101
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/486/06486181.pdf
[firstpage_image] =>[orig_patent_app_number] => 09691845
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/691845 | Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states | Oct 17, 2000 | Issued |
Array
(
[id] => 1298370
[patent_doc_number] => 06627649
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-09-30
[patent_title] => 'Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin V receptors, even of V1 a and V2 receptors'
[patent_app_type] => B1
[patent_app_number] => 09/622778
[patent_app_country] => US
[patent_app_date] => 2000-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4576
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/627/06627649.pdf
[firstpage_image] =>[orig_patent_app_number] => 09622778
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/622778 | Pharmaceutical compositions containing in combination two antagonists selective of arginine-vassopressin V receptors, even of V1 a and V2 receptors | Oct 5, 2000 | Issued |
| 09/660297 | Pharmaceutical compositions containing lipase inhibitors | Sep 12, 2000 | Abandoned |
| 09/486583 | Use of polycyclic steroid compounds for the manufacture of a medicament for the treatment of cystic kidney diseases, vascular infarction, uremia and related conditions | Aug 31, 2000 | Abandoned |
Array
(
[id] => 1495719
[patent_doc_number] => 06403640
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-11
[patent_title] => 'Method for treating chronic prostatitis or chronic pelvic pain syndrome'
[patent_app_type] => B1
[patent_app_number] => 09/644998
[patent_app_country] => US
[patent_app_date] => 2000-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1867
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/403/06403640.pdf
[firstpage_image] =>[orig_patent_app_number] => 09644998
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/644998 | Method for treating chronic prostatitis or chronic pelvic pain syndrome | Aug 23, 2000 | Issued |
| 09/622624 | Combination of a selective nmda nr2b antagonist and a cox-2 inhibitor | Aug 20, 2000 | Abandoned |
| 09/622187 | Combination of formoterol and mometasone in a pharmaceutical composition for treating respiratory disorders, such as asthma, rhintis and copd | Aug 10, 2000 | Abandoned |
| 09/633389 | Methods of treating cancer and the pain associated therewith using endothelin antagonists | Aug 6, 2000 | Abandoned |
Array
(
[id] => 1596688
[patent_doc_number] => 06492428
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-10
[patent_title] => 'Compounds having MIF antagonist activity'
[patent_app_type] => B1
[patent_app_number] => 09/625829
[patent_app_country] => US
[patent_app_date] => 2000-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 13553
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/492/06492428.pdf
[firstpage_image] =>[orig_patent_app_number] => 09625829
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/625829 | Compounds having MIF antagonist activity | Jul 25, 2000 | Issued |
Array
(
[id] => 7636404
[patent_doc_number] => 06380255
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-30
[patent_title] => 'Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds'
[patent_app_type] => B1
[patent_app_number] => 09/617052
[patent_app_country] => US
[patent_app_date] => 2000-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 9
[patent_no_of_words] => 6678
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/380/06380255.pdf
[firstpage_image] =>[orig_patent_app_number] => 09617052
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/617052 | Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds | Jul 13, 2000 | Issued |
| 09/607562 | Methods and compositions for treating diseases and conditions of the eye | Jun 28, 2000 | Abandoned |
| 09/582443 | BONE-RESORPTIVE CYTOKINE INHIBITOR CONTAINING DIENOGEST AS THE ACTIVE INGREDIENT | Jun 25, 2000 | Abandoned |
| 09/581232 | MEDICINAL COMPOSITION FOR PERCUTANEOUS ADMINISTRATION | Jun 22, 2000 | Abandoned |
| 09/485262 | USE OF A RETINOID TYPE COMPOUND TO MODULATE IN VIVO THE DECOUPLING ACTIVITY OF THE PROTEIN UCP2 | May 21, 2000 | Abandoned |
| 09/567034 | Anadamide and structurally related lipids as vanilloid receptor modulators | May 7, 2000 | Abandoned |
Array
(
[id] => 6604286
[patent_doc_number] => 20020015722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'Food product'
[patent_app_type] => new
[patent_app_number] => 09/564662
[patent_app_country] => US
[patent_app_date] => 2000-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3121
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20020015722.pdf
[firstpage_image] =>[orig_patent_app_number] => 09564662
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/564662 | Food product | May 2, 2000 | Abandoned |
Array
(
[id] => 1404937
[patent_doc_number] => 06534534
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-18
[patent_title] => 'Pharmaceutical composition active in reducing production of MCP-1 protein'
[patent_app_type] => B1
[patent_app_number] => 09/463666
[patent_app_country] => US
[patent_app_date] => 2000-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1781
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/534/06534534.pdf
[firstpage_image] =>[orig_patent_app_number] => 09463666
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/463666 | Pharmaceutical composition active in reducing production of MCP-1 protein | Apr 26, 2000 | Issued |
Array
(
[id] => 1478682
[patent_doc_number] => 06451807
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-17
[patent_title] => 'Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor'
[patent_app_type] => B1
[patent_app_number] => 09/558911
[patent_app_country] => US
[patent_app_date] => 2000-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9249
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/451/06451807.pdf
[firstpage_image] =>[orig_patent_app_number] => 09558911
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/558911 | Methods of treating sexual dysfunction in an individual suffering from a retinal disease, class 1 congestive heart failure, or myocardial infarction using a PDE5 inhibitor | Apr 25, 2000 | Issued |
| 09/556930 | Synergistic effects of amlodipine and atorvastatin or atorvastatin metabolitte as a basis for combination therapy | Apr 20, 2000 | Abandoned |
Array
(
[id] => 4327449
[patent_doc_number] => 06329416
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Combination regimens using 3,3-substituted indoline derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/552631
[patent_app_country] => US
[patent_app_date] => 2000-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11741
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1047
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329416.pdf
[firstpage_image] =>[orig_patent_app_number] => 552631
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/552631 | Combination regimens using 3,3-substituted indoline derivatives | Apr 18, 2000 | Issued |
